April 24, 2020, 13:58
The COVID-19 infection has spread rapidly around the world, taking life after life. And the worst thing is that there is no cure for it. However, medical experts are working hard to find a vaccine. And it seems that the scientists of Switzerland and Israel managed to get closer to victory.
Information has appeared in the foreign press about the intentions of Switzerland to start testing its own vaccine against coronavirus infection. One of the first to announce this was in the laboratory of Martin Bachmann from the Institute of Immunology at the University of Bern (Switzerland). According to local doctors, they have developed an effective RBD vaccine against the causative agent of the coronavirus COVID-19.
“Our chances of success are very good. One of the characteristics of Switzerland as a country is its pragmatism. And when it comes to accelerating the process of finding a (such) vaccine (like this one), all interested institutions and structures here are rather inclined to find a generally recognized compromise, showing a willingness to work in concert,”
- commented the head of the Institute Martin Bachmann.
According to the scientist, the created drug will act as an irritant to the immune system using a binding domain (RBD). That is, that part of the protein spikes on the surface of the virus that attaches to receptors on human cells, allowing it to penetrate.
Swiss scientists claim that this vaccine differs from antiviral drugs from other laboratories and is based on a unique approach. It uses some kind of “virus-like particles”. Unlike the virus itself, they are not infectious and therefore provide the body with a good immune response.
Interestingly, the prototype vaccine of Martin Bachmann’s laboratory was created back in February 2020, when the genome of SARS-CoV‑2, which causes a coronavirus disease, was deciphered. Scientists have high hopes for the success of their own drug and hope to conduct clinical trials by mid-autumn.
Israel is not far behind
Meanwhile, Israel is preparing for personal trials. Already in the summer, experts will begin human testing of vaccines against coronavirus, as reported in the local press, citing the Israeli vaccine development company MigVax.
According to the company, the first tests will start in May. First, scientists will test the effectiveness and safety of the vaccine in rodents, and in the summer they will conduct the first stage of clinical trials in humans.
Testing will last from six to nine months, and as a cure, Israeli doctors will adapt the vaccine against avian infectious pneumonia into an oral vaccine against COVID-19. The result of the experiment is possible, scientists believe, since the diseases are genetically and mechanically similar. In their opinion, such a vaccine will contribute to a complex response of the immune system.
What foreign tests will lead to and whether it will really be possible to get a vaccine against coronavirus, we will be watching. In the meantime, take care of yourself, stay at home and follow preventive measures.
The opinion of the editors may not coincide with the opinion of the author of the article.